Terry Wahls’ treatment method for multiple sclerosis, the Wahls Protocol, has already gained a large following online — but with a best-selling book and a TEDtalk with more than 3 million views, she ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

The study evaluates A-tDCS combined with VR exergame training for cognitive dysfunction in MS patients, aiming to assess both short-term and sustained effects. Eighty MS patients with confirmed ...

CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive®, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access to expert-driven, ...

Facet Biotech Announces Daclizumab Program in Multiple Sclerosis to Advance Company Plans to Request Special Protocol Assessment for Phase 3 Trial REDWOOD CITY, CA, Aug 03, 2009 -- Facet Biotech ...

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a ...

Multiple sclerosis (MS) is a condition that affects your brain and spinal cord. It damages the myelin sheath, the tissue that surrounds and protects your nerve cells. This damage blocks or slows down ...

Tiziana Life Sciences ( ($TLSA) ) just unveiled an update. On December 29, 2025, Tiziana Life Sciences reported that it has filed its seventh ...

A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of the disease didn’t hit its main goal.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Multiple sclerosis can affect many areas of your daily life, including dental care. Symptoms of multiple sclerosis and the medications you take for these symptoms can lead to an increased need for ...